RH

Relativity Healthcare Partners

North America, California, United States, Irvine

Description

Relativity Healthcare Partners focuses on providing growth funding to emerging healthcare enterprises.

Investor Profile

Relativity Healthcare Partners has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Medical, Health Care, Biotechnology.

Stage Focus

  • Series A (38%)
  • Seed (25%)
  • Series D (13%)
  • Series B (13%)
  • Series Unknown (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical Device
  • Consulting
  • Legal
  • Saas
  • Software
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Relativity Healthcare Partners frequently co-invest with?

GH
North America, Minnesota, United States, Minnetonka
Co-Investments: 1
Cochlear
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
CRG
North America, Texas, United States, Houston
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Exor Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
BH
Europe, Vilniaus Apskritis, Lithuania, Vilnius
Co-Investments: 1
Andrew W. Mellon Foundation
North America, New York, United States, New York
Co-Investments: 1
Far East Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
AH
North America, Delaware, United States, Dover
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Relativity Healthcare Partners often collaborate with?

Josef Volman
North America, Massachusetts, United States, Boston
Shared Deals: 1
EJ
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Relativity Healthcare Partners?

Anodyne Nanotech

Boston, Massachusetts, United States

Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.

BiopharmaBiotechnologyPharmaceutical
SeedMay 3, 2021
Amount Raised: $4,200,000
Burns & Levinson

Boston, Massachusetts, United States

Burns & Levinson is a Boston-based, full service law firm with more than 125 attorneys in Massachusetts, New York and Rhode Island.

ConsultingLegal
SeedApr 8, 2021
Amount Raised: $4,200,000
Earlens

Menlo Park, California, United States

Earlens is a medical technology company transforming the hearing experience with the only direct sound delivery system.

Health CareMedicalMedical Device
Series DOct 22, 2018
Amount Raised: $87,000,000
OrphoMed

Mill Valley, California, United States

OrphoMed is a San Francisco Bay Area pharmaceutical company focused on the development of novel

BiotechnologyMedicalPharmaceutical
Series AMay 24, 2017
Amount Raised: $39,000,000
LensGen

Irvine, California, United States

LensGen creates adaptive intraocular lenses for the treatment of presbyopia.

Health CareMedicalMedical Device
Series AMay 1, 2017
Amount Raised: $21,000,000
TenNor Therapeutics

Westfield, New Jersey, United States

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

BiotechnologyMedicalTherapeutics
Series BSep 19, 2016
Amount Raised: $25,000,000
BeneStream

New York, New York, United States

BeneStream provides medical aid solutions that help employers make choices in complying with the Affordable Care Act.

Health CareMedicalSaaSSoftware
Series AJul 8, 2015
Amount Raised: $4,260,000
BioAnalytix

Boston, Massachusetts, United States

BioAnalytix works with pharmaceutical partners for the development and commercialization of biologic and biosimilar drugs.

BiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series UnknownOct 24, 2013
Amount Raised: $3,750,000